Horm Metab Res 2019; 51(11): 735-740
DOI: 10.1055/a-1012-8571
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Urine Proteomics Profiling and Functional Characterization of Knee Osteoarthritis Using iTRAQ Technology

Ke Xiao
1   Department of Orthopedic Surgery, Peking Union Medical College Hospital, Beijing, China
2   Department of Orthopaedic Surgery, West China Hospital, Sichuan University, Chengdu, China
,
Lingjia Yu
3   Department of Orthopaedic, Beijing Friendship Hospital, Capital Medical University, Beijing, China
,
Lisi Zhu
4   Laboratory of Clinical Genetics, Peking Union Medical College Hospital, Beijing, China
,
Zhihong Wu
5   Department of Central Laboratory, Peking Union Medical College Hospital, Beijing, China
,
Xisheng Weng
1   Department of Orthopedic Surgery, Peking Union Medical College Hospital, Beijing, China
,
Guixing Qiu
1   Department of Orthopedic Surgery, Peking Union Medical College Hospital, Beijing, China
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 04. August 2018

accepted 10. September 2019

Publikationsdatum:
04. November 2019 (online)

Zoom Image

Abstract

Osteoarthritis (OA) is a degenerative chronic disease affecting the whole joint structures. With the increment in life expectancy and aging population, OA has become one of the largest socioeconomic burdens, associated with pain and loss of joint function. However, early laboratory tests of OA are still lacking. Therefore, new diagnostic tests for this disease are urgently needed. In this study, to gain an insight into the pathogenesis and the potential biomarkers of OA, we implemented a comparative urine proteomics study on OA patients and health people using iTRAQ-based mass spectrometry technology. Western blotting was used to validate the relative changes in urine protein levels for four of the identified proteins. We constructed a comprehensive urine proteome profile of the OA patients and identified 102 proteins differently changed in abundance. Forty-six proteins were upregulated and 56 proteins were significantly downregulated in OA patients. Furthermore, the proteins, COL-4, MMP9, adiponectin, and BBOX1 were validated through Western blots, which can serve as valuable candidate biomarkers and help to illustrate the pathogenesis of OA. These findings may provide clues for promising biomarkers for the early diagnosis and also offer a theoretical basis for the early treatment of OA.

Supplementary Material

Crossref Cited-by logo
Article Citations